Unknown

Dataset Information

0

Lyn kinase promotes erythroblast expansion and late-stage development.


ABSTRACT: Lyn kinase is known to modulate the formation and function of B cells, monocytes, and mast cells. However, Lyn-/- mice also develop erythrosplenomegaly, and cases for both negative and positive erythropoietic actions of Lyn recently have been outlined. In phenylhydrazine-treated Lyn-/- mice, extramedullary splenic erythropoiesis was hyperactivated, but this did not lead to accelerated recovery from anemia. Furthermore, ex vivo analyses of the development of bone marrow-derived Lyn-/- erythroblasts in unique primary culture systems indicated positive roles for Lyn at 2 stages. Late-stage Lyn-/- erythroblasts exhibited deficit Ter119(pos) cell formation, and this was paralleled by increased apoptosis (and decreased Bcl-xL expression). During early development, Lyn-/- erythroblasts accumulated at a Kit(pos)CD71(high) stage, possessed decreased proliferative capacity, and were attenuated in entering an apparent G1/S cell-cycle phase. In proposed compensatory responses, Lyn-/- erythroblasts expressed increased levels of activated Akt and p60-Src and decreased levels of death-associated protein kinase-2. Stat5 activation and Bcl-xL expression, in contrast, were significantly decreased in keeping with decreased survival and developmental potentials. Lyn, therefore, is proposed to function via erythroid cell-intrinsic mechanisms to promote progenitor cell expansion beyond a Kit(pos)CD71(high) stage and to support subsequent late-stage development.

SUBMITTER: Karur VG 

PROVIDER: S-EPMC1895506 | biostudies-literature | 2006 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lyn kinase promotes erythroblast expansion and late-stage development.

Karur Vinit G VG   Lowell Clifford A CA   Besmer Peter P   Agosti Valter V   Wojchowski Don M DM  

Blood 20060516 5


Lyn kinase is known to modulate the formation and function of B cells, monocytes, and mast cells. However, Lyn-/- mice also develop erythrosplenomegaly, and cases for both negative and positive erythropoietic actions of Lyn recently have been outlined. In phenylhydrazine-treated Lyn-/- mice, extramedullary splenic erythropoiesis was hyperactivated, but this did not lead to accelerated recovery from anemia. Furthermore, ex vivo analyses of the development of bone marrow-derived Lyn-/- erythroblas  ...[more]

Similar Datasets

| S-EPMC1895369 | biostudies-literature
| S-EPMC4144737 | biostudies-literature
| S-EPMC2570874 | biostudies-literature
| S-EPMC5614417 | biostudies-other
| S-EPMC6281141 | biostudies-other
| S-EPMC7750288 | biostudies-literature
| S-EPMC6737972 | biostudies-literature
| S-EPMC3644234 | biostudies-literature
| S-EPMC8389176 | biostudies-literature
| S-EPMC8091687 | biostudies-literature